Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Invest in a large pharmaceutical company that has their sights set on the obesity market with drugs in development
This drug is a GLP-1 receptor agonist, which mimics a hormone that is naturally produced after we eat
The GIP receptor component is hypothesised to enhance insulin sensitivity and contribute further to appetite regulation, based on preclinical and early clinical data
N Engl J Med 392(1):3344
Dont lie down after eating, and try a short walk after meals
10.1002/adfm.202412335 84 GuoP.ZhangT.LuA.ShiotaC.HuardM.WhitneyK
US$ 22.21
US$ 24.40
US$ 21.92
US$ 25.40
